NCT03784014 2025-12-11MULTISARCInstitut National de la Santé Et de la Recherche Médicale, FrancePhase 3 Active not recruiting603 enrolled
NCT02034110 2023-08-21Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersNovartisPhase 2 Completed206 enrolled 40 charts 2 FDA